Drug: neulasta Quarter: 2016Q3
Total Drug/Injury Combinations: 516 Number of Pages: 26
DRUGNAME | PT | EventCount | |
---|---|---|---|
NEULASTA | Muscle spasms | 7 | view events |
NEULASTA | Pleural effusion | 7 | view events |
NEULASTA | Toxicity to various agents | 7 | view events |
NEULASTA | Vasospasm | 7 | view events |
NEULASTA | White blood cell count abnormal | 7 | view events |
NEULASTA | Application site haemorrhage | 6 | view events |
NEULASTA | Disease progression | 6 | view events |
NEULASTA | Dry mouth | 6 | view events |
NEULASTA | Dyspepsia | 6 | view events |
NEULASTA | Haemoglobin abnormal | 6 | view events |
NEULASTA | Infection | 6 | view events |
NEULASTA | Laboratory test abnormal | 6 | view events |
NEULASTA | Lymphadenopathy | 6 | view events |
NEULASTA | Muscular weakness | 6 | view events |
NEULASTA | Sepsis | 6 | view events |
NEULASTA | Terminal state | 6 | view events |
NEULASTA | Activities of daily living impaired | 5 | view events |
NEULASTA | Adverse drug reaction | 5 | view events |
NEULASTA | Adverse event | 5 | view events |
NEULASTA | Device infusion issue | 5 | view events |
Total Drug/Injury Combinations: 516 Number of Pages: 26
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)